Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus: Difference between revisions
Esther Lee (talk | contribs) No edit summary |
Esther Lee (talk | contribs) (/* ACC / AHA Guidelines for Diabetes Mellitus{{cite journal| author=2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR et al.| title=2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients Wi...) |
||
Line 11: | Line 11: | ||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen"| | ||
<nowiki>"</nowiki>'''1.''' Medical treatment in the acute phase of [[UA/NSTEMI]] and decisions on whether to perform stress testing, [[angiography]], | <nowiki>"</nowiki>'''1.''' Medical treatment in the acute phase of [[UA/NSTEMI]] and decisions on whether to perform stress testing, [[angiography]], and [[revascularization]] should be similar in patients with and without [[diabetes mellitus]]. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level A]])<nowiki>"</nowiki> | ||
|} | |} | ||
Line 19: | Line 19: | ||
[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' For patients with [[UA/NSTEMI]] and multivessel disease, [[CABG]] with use of the internal mammary arteries can be beneficial | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' For patients with [[UA/NSTEMI]] and multivessel disease, [[CABG]] with use of the internal mammary arteries can be beneficial over [[PCI]] in patients being treated for [[diabetes mellitus]]. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' [[PCI]] is reasonable for [[UA/NSTEMI]] patients with [[diabetes mellitus]] with single-vessel disease and [[inducible ischemia]]. | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' [[PCI]] is reasonable for [[UA/NSTEMI]] patients with [[diabetes mellitus]] with single-vessel disease and [[inducible ischemia]]. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.''' It is reasonable to use an [[insulin]]-based regimen to achieve and maintain glucose levels less than 180 mg/dL while avoiding [[ | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.''' It is reasonable to use an [[insulin]]-based regimen to achieve and maintain glucose levels less than 180 mg/dL while avoiding [[hypoglycemia]]* for hospitalized patients with [[UA/NSTEMI]] with either a complicated or uncomplicated course. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | ||
|} | |} | ||
Revision as of 15:36, 9 October 2012
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
ACC / AHA Guidelines for Diabetes Mellitus[1]
"1. Medical treatment in the acute phase of UA/NSTEMI and decisions on whether to perform stress testing, angiography, and revascularization should be similar in patients with and without diabetes mellitus. (Level A)" |
"1. For patients with UA/NSTEMI and multivessel disease, CABG with use of the internal mammary arteries can be beneficial over PCI in patients being treated for diabetes mellitus. (Level B)" |
"2. PCI is reasonable for UA/NSTEMI patients with diabetes mellitus with single-vessel disease and inducible ischemia. (Level B)" |
"3. It is reasonable to use an insulin-based regimen to achieve and maintain glucose levels less than 180 mg/dL while avoiding hypoglycemia* for hospitalized patients with UA/NSTEMI with either a complicated or uncomplicated course. (Level B)" |
See Also
References
- ↑ 2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR; et al. (2012). "2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 126 (7): 875–910. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849.